IDiyas

For the Inventor, By the Inventor

København K, Denmark

Elsebet Østergaard Nielsen

USPTO Granted Patents = 65 

Average Co-Inventor Count = 4.6

ph-index = 6

Forward Citations = 108(Granted Patents)


Inventors with similar research interests:


Location History:

  • Kobenhavn K, DK (2006)
  • Kobenhavn, DE (2007)
  • Kobenhavn K., DK (2007)
  • Købenkavn K, DK (2010)
  • Ballerup, DK (2007 - 2012)
  • København, DK (2005 - 2014)
  • København K, SE (2014)
  • København K, DK (2005 - 2015)
  • Copenhagen, DK (2010 - 2015)

Company Filing History:

goldMedal59 out of 206 
 
Neurosearch A/s
 patents
silverMedal3 out of 5 
 
Aniona Aps
 patents
bronzeMedal3 out of 3 
 
Danpet Ab
 patents
4. 1 out of 4,177 
 
Abbott Laboratories Corporation
 patents
where one patent can have more than one assignee

Years Active: 2005-2015

Loading Chart...
65 patents (USPTO):Explore Patents
1. 8986654 - Labelled and un-labelled methyl-pyrrolyl-oxadiazolyl-diazabicyclononane derivatives and their medical use (2015-03-24),
2. 8946412 - Diazabicyclononyl oxadiazole compounds and their use as nicotinic acetylcholine receptor modulators (2015-02-03),
3. 8778928 - Indolyl-oxadiazolyl-diazabicyclononane derivatives and their medical and diagnostical use (2014-07-15),
4. 8697721 - Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors (2014-04-15),
5. 8633218 - 8-azabicyclo[3.2.1]oct-2-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors (2014-01-21),
6. 8492408 - [object Object] (2013-07-23),
7. 8372832 - 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use (2013-02-12),
8. 8288418 - [object Object] (2012-10-16),
9. 8263617 - Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors (2012-09-11),
10. 8236793 - Diazabicyclic aryl derivatives as cholinergic receptor modulators (2012-08-07),
11. 8173658 - Diazabicycylic aryl derivatives and their medical use (2012-05-08),
12. 8158619 - 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use (2012-04-17),
13. 8153797 - Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors (2012-04-10),
14. 8148365 - 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use (2012-04-03),
15. 8106042 - 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives useful as modulator of nicotinic acetylcholine receptors (2012-01-31),

Article: Elsebet Østergaard Nielsen: Pioneering Innovator in the Field of Medical Inventions

Introduction:

Elsebet Østergaard Nielsen, a visionary inventor hailing from København K, Denmark, has made significant strides in the realm of medical innovations. With an impressive portfolio of 65 patents to his name, Nielsen's groundbreaking work has revolutionized the field of pharmaceuticals and neuroimaging.

Latest Patents:

Among his latest patents are the "Labelled and un-labelled methyl-pyrrolyl-oxadiazolyl-diazabicyclononane derivatives and their medical use." This invention focuses on the use of certain derivatives in diagnostic methods, particularly in neuroimaging. Additionally, Nielsen's "Diazabicyclononyl oxadiazole compounds and their use as nicotinic acetylcholine receptor modulators" showcases his expertise in developing compounds for the treatment of a wide range of diseases related to the central and peripheral nervous systems.

Career Highlights:

Nielsen's illustrious career includes tenures at renowned companies such as Neurosearch A/S and Aniona ApS. His relentless pursuit of innovation and commitment to creating sustainable solutions have cemented his reputation as a trailblazer in the field of medical inventions. Nielsen's work has not only advanced the field of pharmaceuticals but has also contributed significantly to enhancing patient care and treatment outcomes.

Collaborations:

Throughout his career, Nielsen has collaborated with esteemed professionals in the industry, including Dan Peters and Gunnar M. Olsen. These collaborations have led to the development of groundbreaking inventions and propelled Nielsen's work to new heights. By fostering a culture of teamwork and cooperation, Nielsen has been able to bring his visionary ideas to fruition and make a lasting impact on the field of medical inventions.

Conclusion:

Elsebet Østergaard Nielsen's innovative spirit and dedication to creating a sustainable future through his inventions have solidified his position as a true visionary in the world of medical innovations. His unwavering commitment to pushing the boundaries of what is possible in pharmaceuticals and neuroimaging serves as an inspiration to aspiring inventors and researchers worldwide. Nielsen's contributions to the field will undoubtedly continue to shape the landscape of medical inventions for years to come, leaving a lasting legacy in the pursuit of improved patient care and innovative treatment solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…